Protagonist Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Protagonist Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagonist Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protagonist Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.3M | 29k | 45.00 |
| 2024-06-30 | $1.0M | 30k | 34.65 |
| 2024-03-31 | $862k | 30k | 28.93 |
| 2023-12-31 | $371k | 16k | 22.93 |
| 2023-09-30 | $1.3M | 77k | 16.68 |
| 2023-06-30 | $2.0M | 71k | 27.62 |
| 2022-12-31 | $403 | 37 | 10.92 |
| 2022-09-30 | $19k | 2.3k | 8.26 |
| 2022-06-30 | $48k | 5.6k | 8.59 |
| 2022-03-31 | $616k | 26k | 23.67 |
| 2021-12-31 | $1.4M | 40k | 33.87 |
| 2021-09-30 | $1.1M | 59k | 18.00 |
| 2021-06-30 | $1.3M | 30k | 44.88 |
| 2021-03-31 | $995k | 38k | 25.89 |
| 2020-12-31 | $1.5M | 74k | 20.16 |
| 2020-09-30 | $514k | 26k | 19.58 |
| 2020-06-30 | $268k | 15k | 17.90 |
| 2020-03-31 | $344k | 49k | 7.08 |
| 2019-12-31 | $237k | 34k | 7.09 |
| 2019-09-30 | $313k | 26k | 12.03 |
| 2019-06-30 | $249k | 21k | 12.10 |
| 2019-03-31 | $205k | 16k | 12.54 |
| 2018-12-31 | $123k | 18k | 6.72 |
| 2018-09-30 | $130k | 13k | 10.34 |
| 2018-06-30 | $88k | 13k | 6.68 |
| 2018-03-31 | $73k | 8.5k | 8.54 |
| 2017-12-31 | $115k | 5.5k | 20.87 |
| 2017-06-30 | $67k | 5.9k | 11.30 |
| 2017-03-31 | $67k | 5.2k | 12.84 |
| 2016-12-31 | $115k | 5.2k | 22.03 |